Determination of Estazolam in Plasma by High-Performance Liquid Chromatography with Solid-Phase Extraction.

MIURA Masatomo, OHKUBO Tadashi, SUGAWARA Kazunobu, OKUYAMA Naoyuki, OTANI Koichi

doi:10.2116/analsci.18.525

Determination of Estazolam in Plasma by High-Performance Liquid Chromatography with Solid-Phase Extraction.

DOI PDF Web Site Web Site Web Site PubMed ほか1件をすべて表示一部だけ表示被引用文献1件参考文献32件

MIURA Masatomo

Department of Pharmacy, Hirosaki University Hospital
OHKUBO Tadashi

Department of Pharmacy, Hirosaki University Hospital
SUGAWARA Kazunobu

Department of Pharmacy, Hirosaki University Hospital
OKUYAMA Naoyuki

Department of Neuropsychiatry, Yamagata University Hospital
OTANI Koichi

Department of Neuropsychiatry, Yamagata University Hospital

この論文をさがす

抄録

A high-performance liquid chromatography (HPLC) assay was developed for the determination of estazolam in human plasma. Estazolam and alprazolam as an internal standard were detected by ultraviolet absorbance at 240 nm. Estazolam in plasma was extracted by a rapid and simple procedure based on cyanopropyl bonded-phase extraction. Chromatographic separation was achieved with a reversed-phase C₈-5 column using a mobile phase of 0.5% potassium dihydrogenphosphate(pH 4.5)-acetonitrile (70:30, v/v). The determination of estazolam was possible in the concentration range of 1.0 - 200.0 ng/mL. The mean recovery of estazolam added to plasma was 96.1 ± 1.5% with coefficients of variation of less than 5.5%. This method is applicable for accurately monitoring the plasma level of estazolam in healthy subjects participating in scientific research.